# Age-driven shifts in T and NK cell responses amplify inflammation and coagulopathy during viral infection in mice and humans

**Authors:** Craig P. Collins, Cordelia Dunai, Logan V. Vick, Lam T. Khuat, Alexander Merleev, Eunju (April) Choi, Jonathan Lam, Emanual Maverakis, Arta M. Monjazeb, Dan L. Longo, Nicole Baumgarth, Robert J. Canter, William J. Murphy

PMC · DOI: 10.3389/fimmu.2026.1712726 · Frontiers in Immunology · 2026-02-09

## TL;DR

Older mice and humans show worse outcomes during viral infections due to immune system changes that increase inflammation and blood clotting issues.

## Contribution

The study reveals that advanced age shifts antiviral immunity toward inflammation and coagulopathy, linking these changes to increased mortality in viral infections.

## Key findings

- Advanced aged mice had higher mortality and organ damage despite similar viral loads to younger mice.
- Older mice showed increased inflammation, reduced T cell responses, and coagulopathy during viral infection.
- Findings in mice matched patterns in elderly humans with SARS-CoV-2, including reduced T cell gene expression.

## Abstract

Advanced age is associated with increased morbidity and mortality following acute viral infections, including SARS-CoV-2. Despite this, most preclinical models rely on young animals and fail to account for age-related immune remodeling. How advanced aging alters antiviral immune responses and contributes to immune-mediated pathology remains incompletely understood.

Young (2–6 months), aged (15–18 months), and advanced aged (20–29 months) mice were infected with murine cytomegalovirus (MCMV) or influenza virus. Survival, viral burden, cytokine production, immune cell phenotypes, and tissue pathology were assessed using flow cytometry, histology, serum cytokine analysis, and RNA sequencing. Mouse findings were compared with publicly available transcriptomic datasets from SARS-CoV-2–infected human cohorts across age groups.

Advanced aged mice exhibited markedly increased mortality and organ pathology following viral infection despite maintaining viral loads comparable to younger mice. These outcomes were associated with heightened systemic and tissue inflammatory cytokine production, reduced antigen-specific T cell responses, and increased frequencies of NK cells and non-antigen-specific bystander T cell activation. Coagulopathy with thrombolytic clot formation was observed exclusively in advanced aged mice. Transcriptomic analysis revealed enrichment of inflammatory and coagulation pathways in influenza-infected advanced aged mice, paralleling findings in elderly humans with SARS-CoV-2 infection, who also displayed reduced expression of T cell–associated genes.

These findings demonstrate that advanced age profoundly alters antiviral immune responses, shifting immunity away from effective antigen-specific T cell responses toward inflammatory and innate pathways that contribute to immune-mediated pathology. The results highlight the importance of modeling advanced aging in preclinical studies and suggest that age-dependent immune imbalance may underlie increased inflammation, coagulopathy, and mortality during viral infection in both mice and humans.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Havcr2 (hepatitis A virus cellular receptor 2) [NCBI Gene 171285] {aka TIM-3, Tim3, Timd3}, D9Mgc45e (DNA segment, Chr 9, MRC UK Mouse Genome Centre 45 expressed) [NCBI Gene 28134] {aka CD3}, Nkg7 (natural killer cell group 7 sequence) [NCBI Gene 72310] {aka 2500004F03Rik}, Rorc (RAR-related orphan receptor gamma) [NCBI Gene 19885] {aka Nr1f3, RORgamma, TOR, Thor}, C1qc (complement component 1, q subcomponent, C chain) [NCBI Gene 12262] {aka Adib, C1qg, Ciqc}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Irf9 (interferon regulatory factor 9) [NCBI Gene 16391] {aka Irf-9, Isgf3g, p48}, Tigit (T cell immunoreceptor with Ig and ITIM domains) [NCBI Gene 100043314] {aka Vstm3}, Pros1 (protein S (alpha)) [NCBI Gene 19128], Pdcd1 (programmed cell death 1) [NCBI Gene 18566] {aka Ly101, PD-1, Pdc1}, Isg15 (ISG15 ubiquitin-like modifier) [NCBI Gene 100038882] {aka G1p2, IGI15, IP17, Irfp, UCRP}, Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Nlrc4 (NLR family, CARD domain containing 4) [NCBI Gene 268973] {aka 9530011P19Rik, CLAN, CLAN1, CLANA, CLANB, CLANC}, Il27 (interleukin 27) [NCBI Gene 246779] {aka IL-27, IL-27-A, IL-27p28, IL27-A, Il30, p28}, Ifit1 (interferon-induced protein with tetratricopeptide repeats 1) [NCBI Gene 15957] {aka GARG-16, IFI-56K, ISG56, Ifi56, P56}, Klrb1c (killer cell lectin-like receptor subfamily B member 1C) [NCBI Gene 17059] {aka CD161, Klrb1b, Ly-59, Ly55c, Ly59, NK-RP1}, Prf1 (perforin 1 (pore forming protein)) [NCBI Gene 18646] {aka Pfn, Pfp, Prf-1}, Ace2 (angiotensin converting enzyme 2) [NCBI Gene 70008] {aka 2010305L05Rik}, Lag3 (lymphocyte-activation gene 3) [NCBI Gene 16768] {aka CD223, LAG-3, Ly66}, Irak4 (interleukin-1 receptor-associated kinase 4) [NCBI Gene 266632] {aka 8430405M07Rik, 9330209D03Rik, IRAK-4, NY-REN-64}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, Trem1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 58217], C1qb (complement component 1, q subcomponent, beta polypeptide) [NCBI Gene 12260] {aka Adia}, Adra2a (adrenergic receptor, alpha 2a) [NCBI Gene 11551] {aka Adra-2, Adra-2a, alpha(2A)AR, alpha2-C10, alpha2A, alpha2A-AR}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Il2ra (interleukin 2 receptor, alpha chain) [NCBI Gene 16184] {aka CD25, Il2r, Ly-43}, Socs1 (suppressor of cytokine signaling 1) [NCBI Gene 12703] {aka Cish1, Cish7, JAB, SOCS-1, SSI-1}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Klra21 (killer cell lectin-like receptor subfamily A, member 21) [NCBI Gene 93968] {aka Klra-ps1, Ly49H, Ly49u}, Irf7 (interferon regulatory factor 7) [NCBI Gene 54123], Thbd (thrombomodulin) [NCBI Gene 21824] {aka CD141, TM}, Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Map3k11 (mitogen-activated protein kinase kinase kinase 11) [NCBI Gene 26403] {aka 2610017K16Rik, Mlk3, PTK1, SPRK}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, Adamts13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) [NCBI Gene 279028] {aka ADAM-TS13, ADAMTS-13, Gm710, vWF-CP}, Il1rn (interleukin 1 receptor antagonist) [NCBI Gene 16181] {aka F630041P17Rik, IL-1ra}, Plau (plasminogen activator, urokinase) [NCBI Gene 18792] {aka u-PA, uPA}, Ctla4 (cytotoxic T-lymphocyte-associated protein 4) [NCBI Gene 12477] {aka Cd152, Ctla-4, Ly-56}, Plp1 (proteolipid protein (myelin) 1) [NCBI Gene 18823] {aka DM20, Plp, jimpy, jp, msd, rsh}, Klrk1 (killer cell lectin-like receptor subfamily K, member 1) [NCBI Gene 27007] {aka D6H12S2489E, NKG2-D, Nkg2d}, Socs3 (suppressor of cytokine signaling 3) [NCBI Gene 12702] {aka Cis3, Cish3, EF-10, Ef10, SSI-3, Ssi3}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Irf1 (interferon regulatory factor 1) [NCBI Gene 16362] {aka Irf-1}, Ccl7 (C-C motif chemokine ligand 7) [NCBI Gene 20306] {aka MCP-3, Scya7, fic, marc, mcp3}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, Krt18 (keratin 18) [NCBI Gene 16668] {aka CK18, K18, Krt1-18}, Map2k2 (mitogen-activated protein kinase kinase 2) [NCBI Gene 26396] {aka MEK2, MK2, Prkmk2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nfatc2 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2) [NCBI Gene 18019] {aka NF-ATc2, NF-ATp, NFAT1, NFAT1-D, Nfatp}, Eomes (eomesodermin) [NCBI Gene 13813] {aka TBR-2, Tbr2}, Serpine1 (serine (or cysteine) peptidase inhibitor, clade E, member 1) [NCBI Gene 18787] {aka PAI-1, PAI1, Planh1}, Mapk11 (mitogen-activated protein kinase 11) [NCBI Gene 19094] {aka P38b, Prkm11, Sapk2, Sapk2b, p38-2, p38beta}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Nfatc4 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4) [NCBI Gene 73181] {aka 3110041H08Rik, Nfat3}
- **Diseases:** tissue injury (MESH:D017695), necrosis (MESH:D009336), storm (MESH:C566109), inflammatory dysregulation (MESH:D021081), immune dysregulation (OMIM:614878), dislocation (MESH:D004204), interstitial pneumonia (MESH:D017563), hepatitis (MESH:D056486), MCMV infection (MESH:D003586), obesity (MESH:D009765), bacterial and (MESH:D001424), respiratory arrest (MESH:D012131), inflammatory cytokines (MESH:D000080424), bronchiolar epithelial hyperplasia (MESH:D017573), leukocytosis (MESH:D007964), weight loss (MESH:D015431), vascular dysfunction (MESH:D002561), cancer (MESH:D009369), lungs (MESH:D008171), COVID (MESH:D000086382), immune dysfunction (MESH:D007154), hypertrophy (MESH:D006984), Coagulopathy (MESH:D001778), infected (MESH:D007239), lipidosis (MESH:D008064), viral (MESH:D014777), type II pneumoctes hyperplasia (MESH:C538236), Influenza (MESH:D007251), bronchiolar epithelial necrosis (MESH:D009375), Inflammatory (MESH:D007249)
- **Chemicals:** poly-T (MESH:D011071), Formalin (MESH:D005557), heparin (MESH:D006493), eosin (MESH:D004801), isoflurane (MESH:D007530), LPS (MESH:D008070), nitrogen (MESH:D009584), hematoxylin (MESH:D006416), oxygen (MESH:D010100), H&amp;E (MESH:D006371), Percoll (MESH:C016039), paraffin (MESH:D010232), Hank's Balanced Salt Solution (-)
- **Species:** Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Enterovirus C (no rank) [taxon 138950], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Murid betaherpesvirus 1 (Murine cytomegalovirus, no rank) [taxon 10366]
- **Cell lines:** M2-10B4 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_5794), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926148/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926148/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926148/full.md

---
Source: https://tomesphere.com/paper/PMC12926148